Skip to Main Content

Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer

Conditions

Prostate

Phase II

What is the purpose of this trial?

This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.

  • Trial with
    Eastern Coop Onc Group-American College Radiology Imaging Netwk(ECOG-ACRIN)
  • Start Date
    08/15/2019
  • End Date
    07/31/2020

For more information about this study, contact:

Svetlana Vassilieva

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    09/18/2019
  • Study HIC
    #2000024244